Buprenorphine inactive ingredients by manufacturer
Wondering whether your Buprenorphine has lactose, gluten, soy, a dye or gelatin in it? The medicine is the same, but the fillers, coatings and colors differ from one company to the next. This page shows what each Buprenorphine product's FDA label lists, so you can find a version that leaves out what you avoid and ask your pharmacist for it by its NDC.
We have read the FDA labels of 83 of the 106 current Buprenorphine products on the market today, from 32 companies listing it with the FDA, and lined them up side by side. 22 are still being read and will appear on a later visit. 1 could not be linked to a current label.
Ask about your bottle
Is there something in your Buprenorphine? Ask in plain words.
Name the company, strength or the NDC on your bottle and the ingredient you avoid. The answer comes only from the FDA labels on this page.
Answers are drawn from the FDA label data on this page and checked against it. They are not medical advice: confirm with your pharmacist before relying on them.
The short answer
Which Buprenorphine products list lactose, a gluten source, soy, dyes or gelatin?
-
LactoseDiffers by manufacturer
46 of 83 checked products list lactose; 37 do not. See the products
-
Wheat or gluten sourceNo checked product
No checked Buprenorphine product lists a wheat or gluten source.
-
SoyDiffers by manufacturer
3 of 83 checked products list soy; 80 do not. See the products
Does not list it A-S Medication Solutions Actavis Advagen Alvogen American Health Packaging Amneal Aveva Drug Delivery Systems BioDelivery Sciences Bryant Ranch Prepack Camber Clinical Solutions Wholesale Direct_Rx Direct_rx Hikma Hospira Indivior Ingenus Knoa Major PAI Holdings, LLC dba PAI Par Health Redpharm Drug Remedyrepack Rhodes Somerset Therapeutics SpecGx Sun Teva Unit Dose SolutionsLists it Braeburn -
Synthetic dyesDiffers by manufacturer
3 of 83 checked products list synthetic dyes; 80 do not. See the products
Does not list it A-S Medication Solutions Advagen Alvogen American Health Packaging Amneal Aveva Drug Delivery Systems BioDelivery Sciences Braeburn Bryant Ranch Prepack Camber Clinical Solutions Wholesale Direct_Rx Direct_rx Hikma Hospira Indivior Ingenus Knoa Major PAI Holdings, LLC dba PAI Par Health Redpharm Drug Remedyrepack Rhodes Somerset Therapeutics SpecGx Sun Teva Unit Dose Solutions -
GelatinNo checked product
No checked Buprenorphine product lists gelatin.
Also listed by some products: Corn 46 of 83 Titanium dioxide 4 of 83 Alcohol 2 of 83 Propylene glycol 4 of 83 Sorbitol or mannitol 46 of 83 Sugar 4 of 83
Find a version without it
Every current Buprenorphine product and what its label lists
| Product | Lists | Inactive ingredients on the label |
|---|---|---|
| A-S Medication Solutions 2 products | ||
| 8 mg sublingual tabletNDC 50090-5805-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsAnhydrous Citric Acid, CROSPOVIDONE, Lactose monohydrate, Magnesium Stearate, Mannitol, Povidone K30, Starch, Corn, Trisodium Citrate Dihydrate |
| 8 mg sublingual tabletNDC 50090-7559-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE K30, SODIUM STEARYL FUMARATE, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Actavis Pharma, Inc. 2 products | ||
| 2 mg sublingual tabletNDC 00228-3156-03 | Lactose Corn-derived Synthetic dyes Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (15 MPA.S AT 5%), FD&C YELLOW NO. 6, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 00228-3153-03 | Lactose Corn-derived Synthetic dyes Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (15 MPA.S AT 5%), FD&C YELLOW NO. 6, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Advagen Pharma Ltd 4 products | ||
| 2 mg sublingual tabletNDC 72888-0182-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 6 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 4 mg sublingual tabletNDC 72888-0509-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 6 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 72888-0183-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 6 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 12 mg sublingual tabletNDC 72888-0510-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 6 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Alvogen Inc. 4 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 47781-0406-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE K90 |
| BUPRENORPHINE 10 mcg/h skin patchNDC 47781-0407-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE K90 |
| BUPRENORPHINE 15 mcg/h skin patchNDC 47781-0419-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE K90 |
| BUPRENORPHINE 20 mcg/h skin patchNDC 47781-0408-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE K90 |
| American Health Packaging 2 products | ||
| 2 mg sublingual tabletNDC 60687-0481-21 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 60687-0492-21 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Amneal Pharmaceuticals NY LLC 5 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 69238-1202-02 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 69238-1505-02 | Still being read | Not read yet |
| BUPRENORPHINE 10 mcg/h skin patchNDC 69238-1203-02 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE |
| BUPRENORPHINE 15 mcg/h skin patchNDC 69238-1204-02 | Still being read | Not read yet |
| BUPRENORPHINE 20 mcg/h skin patchNDC 69238-1205-02 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE |
| Aveva Drug Delivery Systems Inc. 5 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 03215-1521-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 03215-1522-04 | Still being read | Not read yet |
| BUPRENORPHINE 10 mcg/h skin patchNDC 03215-1523-04 | Still being read | Not read yet |
| BUPRENORPHINE 15 mcg/h skin patchNDC 03215-1524-04 | Still being read | Not read yet |
| BUPRENORPHINE 20 mcg/h skin patchNDC 03215-1525-04 | Still being read | Not read yet |
| AvPAK 2 products | ||
| 2 mg sublingual tabletNDC 50268-0128-15 | Still being read | Not read yet |
| 8 mg sublingual tabletNDC 50268-0129-15 | Still being read | Not read yet |
| BioDelivery Sciences International Inc 7 products | ||
| 75 mcg buccal filmNDC 59385-0021-60 | Titanium dioxide Propylene glycol |
Show 16 ingredients.ALPHA.-TOCOPHEROL ACETATE, ANHYDROUS CITRIC ACID, CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%), Ferric Oxide Yellow, HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%), HYDROXYPROPYL CELLULOSE (90000 WAMW), Methylparaben, Peppermint Oil, Polycarbophil, Propylene Glycol, Propylparaben, Saccharin Sodium, Sodium Benzoate, Sodium Hydroxide, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, Titanium Dioxide |
| 150 mcg buccal filmNDC 59385-0022-60 | Still being read | Not read yet |
| 300 mcg buccal filmNDC 59385-0023-60 | Titanium dioxide Propylene glycol |
Show 16 ingredients.ALPHA.-TOCOPHEROL ACETATE, ANHYDROUS CITRIC ACID, CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%), Ferric Oxide Yellow, HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%), HYDROXYPROPYL CELLULOSE (90000 WAMW), Methylparaben, Peppermint Oil, Polycarbophil, Propylene Glycol, Propylparaben, Saccharin Sodium, Sodium Benzoate, Sodium Hydroxide, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, Titanium Dioxide |
| 450 mcg buccal filmNDC 59385-0024-60 | Still being read | Not read yet |
| 600 mcg buccal filmNDC 59385-0025-60 | Titanium dioxide Propylene glycol |
Show 16 ingredients.ALPHA.-TOCOPHEROL ACETATE, ANHYDROUS CITRIC ACID, CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%), Ferric Oxide Yellow, HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%), HYDROXYPROPYL CELLULOSE (90000 WAMW), Methylparaben, Peppermint Oil, Polycarbophil, Propylene Glycol, Propylparaben, Saccharin Sodium, Sodium Benzoate, Sodium Hydroxide, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, Titanium Dioxide |
| 750 mcg buccal filmNDC 59385-0026-60 | Still being read | Not read yet |
| 900 mcg buccal filmNDC 59385-0027-60 | Titanium dioxide Propylene glycol |
Show 16 ingredients.ALPHA.-TOCOPHEROL ACETATE, ANHYDROUS CITRIC ACID, CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%), Ferric Oxide Yellow, HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%), HYDROXYPROPYL CELLULOSE (90000 WAMW), Methylparaben, Peppermint Oil, Polycarbophil, Propylene Glycol, Propylparaben, Saccharin Sodium, Sodium Benzoate, Sodium Hydroxide, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, Titanium Dioxide |
| Braeburn Inc. 7 products | ||
| 8 mg/0.16 mL injectionNDC 58284-0208-01 | Soy Alcohol (ethanol) |
Show 3 ingredientsALCOHOL, GLYCERYL DIOLEATE, LECITHIN, SOYBEAN |
| 16 mg/0.32 mL injectionNDC 58284-0216-01 | Still being read | Not read yet |
| 24 mg/0.48 mL injectionNDC 58284-0224-01 | Still being read | Not read yet |
| 32 mg/0.64 mL injectionNDC 58284-0232-01 | Soy Alcohol (ethanol) |
Show 3 ingredientsALCOHOL, GLYCERYL DIOLEATE, LECITHIN, SOYBEAN |
| 64 mg/0.18 mL injectionNDC 58284-0264-01 | Still being read | Not read yet |
| 96 mg/0.27 mL injectionNDC 58284-0296-01 | Still being read | Not read yet |
| 128 mg/0.36 mL injectionNDC 58284-0228-01 | Soy |
Show 3 ingredientsGLYCERYL DIOLEATE, LECITHIN, SOYBEAN, METHYLPYRROLIDONE |
| Bryant Ranch Prepack 7 products | ||
| 2 mg sublingual tabletNDC 72162-1344-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 2 mg sublingual tabletNDC 63629-9475-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 2 mg sublingual tabletNDC 71335-0950-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 71335-1163-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 71335-3152-00 | Still being read | Not read yet |
| 8 mg sublingual tabletNDC 72162-1345-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 71335-1154-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Camber Pharmaceuticals, Inc. 2 products | ||
| 2 mg sublingual tabletNDC 31722-0870-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 11 ingredientsACESULFAME POTASSIUM, ANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 31722-0871-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 11 ingredientsACESULFAME POTASSIUM, ANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| Clinical Solutions Wholesale, LLC 6 products | ||
| 2 mg sublingual tabletNDC 58118-0176-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (15 MPA.S AT 5%), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 2 mg sublingual tabletNDC 58118-0501-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 2 mg sublingual tabletNDC 58118-4459-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| 8 mg sublingual tabletNDC 58118-0177-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (15 MPA.S AT 5%), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 58118-0460-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| 8 mg sublingual tabletNDC 58118-0502-08 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Direct_Rx 2 products | ||
| 2 mg sublingual tabletNDC 72189-0580-60 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 72189-0582-60 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| Direct_rx 1 product | ||
| 2 mg sublingual tabletNDC 72189-0579-60 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| Hikma Pharmaceuticals USA Inc. 3 products | ||
| 0.324 mg/mL injectionNDC 00143-9246-05 | Sugar (sucrose, dextrose) |
Show 3 ingredientsANHYDROUS DEXTROSE, HYDROCHLORIC ACID, WATER |
| 2 mg sublingual tabletNDC 00054-0176-13 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 00054-0177-13 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| Hospira, Inc. 1 product | ||
| 0.3 mg/mL injectionNDC 00409-2012-32 | Sugar (sucrose, dextrose) |
Show 3 ingredientsANHYDROUS DEXTROSE, HYDROCHLORIC ACID, WATER |
| Indivior Inc. 2 products | ||
| 100 mg injectionNDC 12496-0100-01 | None of these listed |
Show 2 ingredientsMETHYLPYRROLIDONE, POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 15000 MW) |
| 300 mg injectionNDC 12496-0300-01 | None of these listed |
Show 2 ingredientsMETHYLPYRROLIDONE, POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 15000 MW) |
| Ingenus Pharmaceuticals, Llc 5 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 50742-0372-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 50742-0373-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 10 mcg/h skin patchNDC 50742-0374-04 | Still being read | Not read yet |
| BUPRENORPHINE 15 mcg/h skin patchNDC 50742-0375-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 20 mcg/h skin patchNDC 50742-0376-04 | None of these listed |
Show 3 ingredientsLEVULINIC ACID, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| Knoa Pharma LLC 5 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 59011-0750-04 | None of these listed |
Show 3 ingredientsETHYL LEVULINATE, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 59011-0757-04 | None of these listed |
Show 3 ingredientsETHYL LEVULINATE, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| BUPRENORPHINE 10 mcg/h skin patchNDC 59011-0751-04 | Still being read | Not read yet |
| BUPRENORPHINE 15 mcg/h skin patchNDC 59011-0758-04 | Still being read | Not read yet |
| BUPRENORPHINE 20 mcg/h skin patchNDC 59011-0752-04 | None of these listed |
Show 3 ingredientsETHYL LEVULINATE, OLEYL OLEATE, POVIDONE, UNSPECIFIED |
| LTS Therapy Systems, LLC 1 product | ||
| BUPRENORPHINE 20 mcg/h skin patchNDC 58064-0408-04 | No current label | Not available |
| Major Pharmaceuticals 2 products | ||
| 2 mg sublingual tabletNDC 00904-7154-04 | Still being read | Not read yet |
| 8 mg sublingual tabletNDC 00904-7155-04 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| PAI Holdings, LLC dba PAI Pharma 2 products | ||
| 2 mg sublingual tabletNDC 00121-1019-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE K30, SODIUM STEARYL FUMARATE, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 00121-2038-30 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE K30, SODIUM STEARYL FUMARATE, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Par Health USA, LLC 1 product | ||
| 0.324 mg/mL injectionNDC 42023-0179-05 | Sugar (sucrose, dextrose) |
Show 3 ingredientsANHYDROUS DEXTROSE, HYDROCHLORIC ACID, WATER |
| Redpharm Drug 2 products | ||
| 2 mg sublingual tabletNDC 67296-2123-03 | Still being read | Not read yet |
| 8 mg sublingual tabletNDC 67296-2173-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| Remedyrepack Inc. 5 products | ||
| 2 mg sublingual tabletNDC 70518-1557-01 | Lactose Corn-derived Synthetic dyes Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (15 MPA.S AT 5%), FD&C YELLOW NO. 6, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 2 mg sublingual tabletNDC 70518-2226-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 2 mg sublingual tabletNDC 70518-4570-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 6 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 70518-2014-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 9 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE (120 .MU.M), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN, WATER |
| 8 mg sublingual tabletNDC 70518-4571-00 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE K30, SODIUM STEARYL FUMARATE, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| Rhodes Pharmaceuticals LLC 7 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 42858-0750-40 | None of these listed |
Show 3 ingredientsethyl levulinate, oleyl oleate, povidone, unspecified |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 42858-0353-40 | None of these listed |
Show 3 ingredientsethyl levulinate, oleyl oleate, povidone, unspecified |
| BUPRENORPHINE 10 mcg/h skin patchNDC 42858-0493-40 | None of these listed |
Show 3 ingredientsethyl levulinate, oleyl oleate, povidone, unspecified |
| BUPRENORPHINE 15 mcg/h skin patchNDC 42858-0586-40 | None of these listed |
Show 3 ingredientsethyl levulinate, oleyl oleate, povidone, unspecified |
| BUPRENORPHINE 20 mcg/h skin patchNDC 42858-0839-40 | None of these listed |
Show 3 ingredientsethyl levulinate, oleyl oleate, povidone, unspecified |
| 2 mg sublingual tabletNDC 42858-0501-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsAnhydrous Citric Acid, CROSPOVIDONE, UNSPECIFIED, Lactose monohydrate, Magnesium Stearate, Mannitol, Povidone K30, Starch, Corn, Trisodium Citrate Dihydrate |
| 8 mg sublingual tabletNDC 42858-0502-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsAnhydrous Citric Acid, CROSPOVIDONE, UNSPECIFIED, Lactose monohydrate, Magnesium Stearate, Mannitol, Povidone K30, Starch, Corn, Trisodium Citrate Dihydrate |
| Somerset Therapeutics, LLC 1 product | ||
| 0.324 mg/mL injectionNDC 70069-0027-05 | Sugar (sucrose, dextrose) |
Show 3 ingredientsANHYDROUS DEXTROSE, HYDROCHLORIC ACID, WATER |
| SpecGx LLC 2 products | ||
| 2 mg sublingual tabletNDC 00406-7012-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE, SODIUM CITRATE, SODIUM STEARYL FUMARATE, STARCH, CORN |
| 8 mg sublingual tabletNDC 00406-7018-03 | Lactose Corn-derived Sorbitol or mannitol |
Show 7 ingredientsANHYDROUS CITRIC ACID, LACTOSE MONOHYDRATE, MANNITOL, POVIDONE, SODIUM CITRATE, SODIUM STEARYL FUMARATE, STARCH, CORN |
| Sun Pharmaceutical Industries, Inc. 2 products | ||
| 2 mg sublingual tabletNDC 62756-0459-64 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| 8 mg sublingual tabletNDC 62756-0460-64 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, BUTYLATED HYDROXYANISOLE, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE, UNSPECIFIED, SODIUM CITRATE, UNSPECIFIED FORM, STARCH, CORN |
| Teva Pharmaceuticals USA, Inc. 5 products | ||
| BUPRENORPHINE 5 mcg/h skin patchNDC 00093-3656-40 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, LEVULINIC ACID |
| BUPRENORPHINE 7.5 mcg/h skin patchNDC 00093-3239-40 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, LEVULINIC ACID |
| BUPRENORPHINE 10 mcg/h skin patchNDC 00093-3657-40 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, LEVULINIC ACID |
| BUPRENORPHINE 15 mcg/h skin patchNDC 00093-3658-40 | Still being read | Not read yet |
| BUPRENORPHINE 20 mcg/h skin patchNDC 00093-3659-40 | None of these listed |
Show 2 ingredientsCITRIC ACID MONOHYDRATE, LEVULINIC ACID |
| Unit Dose Solutions, Inc. 2 products | ||
| 2 mg sublingual tabletNDC 87441-0011-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
| 8 mg sublingual tabletNDC 87441-0082-01 | Lactose Corn-derived Sorbitol or mannitol |
Show 8 ingredientsANHYDROUS CITRIC ACID, CROSPOVIDONE, UNSPECIFIED, LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, MANNITOL, POVIDONE K30, STARCH, CORN, TRISODIUM CITRATE DIHYDRATE |
A product with none of these listed is not certified to be without them: the label says what the manufacturer declared, and the source of a starch or a flavor is often not stated. The companies are the FDA's labelers, which include repackagers and distributors selling another company's product under their own label. The NDC opens the product's own page, with the full label and its inactive-ingredient notes.
Buprenorphine without lactose
Lactose: milk sugar; a concern with lactose intolerance or a milk allergy. 46 of 83 checked products list lactose; 37 do not.
Does not list lactose
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Hikma: 0.324 mg/mL injection
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Par Health: 0.324 mg/mL injection
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Somerset Therapeutics: 0.324 mg/mL injection
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
Lists lactose
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 2 mg sublingual tablet, 8 mg sublingual tablet
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: 2 mg sublingual tablet, 8 mg sublingual tablet
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Buprenorphine without soy
Soy: soybean oil or soy lecithin; a concern with soy allergy. 3 of 83 checked products list soy; 80 do not.
Does not list soy
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 0.324 mg/mL injection, 2 mg sublingual tablet, 8 mg sublingual tablet
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Par Health: 0.324 mg/mL injection
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- Somerset Therapeutics: 0.324 mg/mL injection
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists soy
Buprenorphine without synthetic dyes
Synthetic dyes: FD&C or D&C colorants and their aluminum lakes. 3 of 83 checked products list synthetic dyes; 80 do not.
Does not list synthetic dyes
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 0.324 mg/mL injection, 2 mg sublingual tablet, 8 mg sublingual tablet
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Par Health: 0.324 mg/mL injection
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- Somerset Therapeutics: 0.324 mg/mL injection
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists synthetic dyes
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet
Buprenorphine without corn-derived ingredients
Corn-derived: corn starch, maize or corn syrup; a concern with corn allergy. 46 of 83 checked products list corn-derived ingredients; 37 do not.
Does not list corn-derived ingredients
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Hikma: 0.324 mg/mL injection
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Par Health: 0.324 mg/mL injection
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Somerset Therapeutics: 0.324 mg/mL injection
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
Lists corn-derived ingredients
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 2 mg sublingual tablet, 8 mg sublingual tablet
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: 2 mg sublingual tablet, 8 mg sublingual tablet
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Buprenorphine without titanium dioxide
Titanium dioxide: A white colorant some people choose to avoid. 4 of 83 checked products list titanium dioxide; 79 do not.
Does not list titanium dioxide
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 0.324 mg/mL injection, 2 mg sublingual tablet, 8 mg sublingual tablet
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Par Health: 0.324 mg/mL injection
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- Somerset Therapeutics: 0.324 mg/mL injection
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists titanium dioxide
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
Buprenorphine without alcohol (ethanol)
Alcohol (ethanol): mostly in liquids; a concern in alcohol recovery, for children, or with disulfiram or metronidazole. 2 of 83 checked products list alcohol (ethanol); 81 do not.
Does not list alcohol (ethanol)
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 128 mg/0.36 mL injection
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 0.324 mg/mL injection, 2 mg sublingual tablet, 8 mg sublingual tablet
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Par Health: 0.324 mg/mL injection
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- Somerset Therapeutics: 0.324 mg/mL injection
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists alcohol (ethanol)
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection
Buprenorphine without propylene glycol
Propylene glycol: A solvent in liquids and capsules; a concern in kidney disease, for infants, and at high doses. 4 of 83 checked products list propylene glycol; 79 do not.
Does not list propylene glycol
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 0.324 mg/mL injection, 2 mg sublingual tablet, 8 mg sublingual tablet
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Par Health: 0.324 mg/mL injection
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- Somerset Therapeutics: 0.324 mg/mL injection
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists propylene glycol
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
Buprenorphine without sorbitol or mannitol
Sorbitol or mannitol: sugar alcohols that can cause bloating or diarrhea in larger amounts. 46 of 83 checked products list sorbitol or mannitol; 37 do not.
Does not list sorbitol or mannitol
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Hikma: 0.324 mg/mL injection
- Hospira: 0.3 mg/mL injection
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Par Health: 0.324 mg/mL injection
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Somerset Therapeutics: 0.324 mg/mL injection
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
Lists sorbitol or mannitol
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 2 mg sublingual tablet, 8 mg sublingual tablet
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: 2 mg sublingual tablet, 8 mg sublingual tablet
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Buprenorphine without sugar (sucrose or dextrose)
Sugar (sucrose, dextrose): A consideration in diabetes, mostly in liquids and chewables. 4 of 83 checked products list sugar (sucrose or dextrose); 79 do not.
Does not list sugar (sucrose or dextrose)
- A-S Medication Solutions: 8 mg sublingual tablet (NDC 50090-5805-00), 8 mg sublingual tablet (NDC 50090-7559-00)
- Actavis: 2 mg sublingual tablet, 8 mg sublingual tablet
- Advagen: 2 mg sublingual tablet, 4 mg sublingual tablet, 8 mg sublingual tablet, 12 mg sublingual tablet
- Alvogen: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- American Health Packaging: 2 mg sublingual tablet, 8 mg sublingual tablet
- Amneal: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Aveva Drug Delivery Systems: BUPRENORPHINE 5 mcg/h skin patch
- BioDelivery Sciences: 75 mcg buccal film, 300 mcg buccal film, 600 mcg buccal film, 900 mcg buccal film
- Braeburn: 8 mg/0.16 mL injection, 32 mg/0.64 mL injection, 128 mg/0.36 mL injection
- Bryant Ranch Prepack: 2 mg sublingual tablet (NDC 72162-1344-03), 2 mg sublingual tablet (NDC 63629-9475-01), 2 mg sublingual tablet (NDC 71335-0950-01), 8 mg sublingual tablet (NDC 71335-1163-00), 8 mg sublingual tablet (NDC 72162-1345-00), 8 mg sublingual tablet (NDC 71335-1154-00)
- Camber: 2 mg sublingual tablet, 8 mg sublingual tablet
- Clinical Solutions Wholesale: 2 mg sublingual tablet (NDC 58118-0176-08), 2 mg sublingual tablet (NDC 58118-0501-08), 2 mg sublingual tablet (NDC 58118-4459-08), 8 mg sublingual tablet (NDC 58118-0177-08), 8 mg sublingual tablet (NDC 58118-0460-08), 8 mg sublingual tablet (NDC 58118-0502-08)
- Direct_Rx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Direct_rx: 2 mg sublingual tablet
- Hikma: 2 mg sublingual tablet, 8 mg sublingual tablet
- Indivior: 100 mg injection, 300 mg injection
- Ingenus: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Knoa: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Major: 8 mg sublingual tablet
- PAI Holdings, LLC dba PAI: 2 mg sublingual tablet, 8 mg sublingual tablet
- Redpharm Drug: 8 mg sublingual tablet
- Remedyrepack: 2 mg sublingual tablet (NDC 70518-1557-01), 2 mg sublingual tablet (NDC 70518-2226-00), 2 mg sublingual tablet (NDC 70518-4570-00), 8 mg sublingual tablet (NDC 70518-2014-00), 8 mg sublingual tablet (NDC 70518-4571-00)
- Rhodes: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 15 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch, 2 mg sublingual tablet, 8 mg sublingual tablet
- SpecGx: 2 mg sublingual tablet, 8 mg sublingual tablet
- Sun: 2 mg sublingual tablet, 8 mg sublingual tablet
- Teva: BUPRENORPHINE 5 mcg/h skin patch, BUPRENORPHINE 7.5 mcg/h skin patch, BUPRENORPHINE 10 mcg/h skin patch, BUPRENORPHINE 20 mcg/h skin patch
- Unit Dose Solutions: 2 mg sublingual tablet, 8 mg sublingual tablet
Lists sugar (sucrose or dextrose)
- Hikma: 0.324 mg/mL injection
- Hospira: 0.3 mg/mL injection
- Par Health: 0.324 mg/mL injection
- Somerset Therapeutics: 0.324 mg/mL injection
At the pharmacy counter
How to use this at the pharmacy counter
- Pick the company whose list suits you and copy the NDC from the table. Many pharmacies order from wholesalers that carry several companies' versions and can request a particular one if you ask before the prescription is filled; some buy from one contracted source only, and a few insurance plans cover only certain NDCs, so ask the pharmacist to check.
- Treat "does not list" as exactly that. The label is what the manufacturer declared; a flavor or a starch may have an unstated source, and lines change. For celiac disease or a serious allergy, ask the manufacturer's medical information line for a written statement about the lot you have.
- Check the bottle each refill. A different company usually means a different shape, color and inactive-ingredient list; the pharmacist can tell you who made it, and the two-NDC comparison shows the difference line by line.
- If you need one company's version kept constant, ask your prescriber to write that company or the NDC on the prescription and tell the pharmacy you need it held. Rules vary by state and plan, so confirm with the pharmacist.
Common questions about Buprenorphine inactive ingredients
Is Buprenorphine gluten-free?
Does Buprenorphine contain lactose?
Does Buprenorphine contain soy?
Is there a dye-free Buprenorphine?
Does Buprenorphine contain gelatin?
Why do the inactive ingredients differ between manufacturers?
Can my pharmacy give me a specific manufacturer's version?
How current is this list?
Sources: the products are the finished Buprenorphine products in the FDA's current NDC directory (openFDA), as of October 5, 2026; each inactive-ingredient list is the manufacturer's FDA Structured Product Label via DailyMed, as our label sync last read it. The concern groups are HelloPharmacist's classification of the names the label declares. Educational information only, not medical advice; confirm with your pharmacist before relying on a list. ← Back to the Buprenorphine guide